Meridian Wealth Partners

Thesis Checkup for CHKP

Research Desk · Thesis Update · 2026-07-04
Confidential — Prepared for Client
01 · Verdict

The verdict on the thesis for CHKP is INTACT. The company's Q2 revenue growth of 4.1% and billings growth of 6% indicate resilience in security spend, supporting Pillar 1. The new CEO's announcement of a platform consolidation push could potentially drive growth reacceleration, aligning with Pillar 2. Furthermore, the buyback pace of $325M per quarter is on track to shrink the share count, confirming Pillar 3.

02 · Pillar-by-Pillar Scorecard

Pillar 1: security spend resilient - confirmed, as evidenced by the positive revenue and billings growth. Pillar 2: new CEO drives growth reacceleration to 8%+ - unresolved, as the impact of the platform consolidation push on growth rates is yet to be determined. Pillar 3: buybacks shrink share count 4%/yr - confirmed, given the current buyback pace.

03 · What Would Change the Verdict

A growth rate of less than 3% would change the verdict to CRACKED or BROKEN, as per the original thesis. Additionally, any significant deviation from the planned buyback pace or failure to deliver on the growth reacceleration promise could alter the verdict.

04 · Updated Catalyst List

The updated catalyst list includes the success of the platform consolidation push, future buyback pace, and competitor dynamics, such as the recent guidance cut by PANW.

05 · Recommended Action

Given the INTACT verdict, the recommended action is to hold the position. Investors should continue to monitor the company's progress on its growth reacceleration initiatives and buyback program, as well as the competitive landscape.